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PREAMBLE
The general reluctance in our society to 
discuss end-of-life issues translates into a 
failure by many to prepare properly for the end 
of life. This includes not making wills, 
expressing wishes about funeral 
arrangements, considering the need to make 
powers of attorney or give directions for care 
through advance directives.
The consequence is that the failure to think in 
advance about end-of-life issues will impact 
not only on the quality of life of the individual in 
their final years and months, but also on those 
around them. End-of-life issues are, by their 
nature, complex, personal and sensitive, but 
they are made all the harder if the wishes of 
the person concerned are not properly 
understood or set out.
The first part of this publication, which was 
released on 4 April 2011, explained the legal 
options that people can exercise now in 
respect of planning for the end of life. These 
include advance care planning, preferred place 
to die, refusal of treatment and withdrawal of 
treatment.
This second publication considers what 
additional options might become available in 
the future that people with dementia could 
access towards the end of their lives. These 
could include euthanasia and assisted suicide.
We take the view that the debate on 
euthanasia is clouded in confusion, particularly 
in relation to the terminology used.
The intention of this publication is not to tell 
people what view they should take, but rather 
to explore issues for and against more active 
approaches to the termination of life.
We are clear that the debate about end-of-life 
issues should not be one about states’ rights, 
but one by people about the lives of the people 
themselves.
We are deeply grateful to Professor Colleen 
Cartwright for undertaking this task and for 
working with the National Consumer Advisory 
Committee. This publication simply would not 
have been possible without the commitment 
and experience of Professor Cartwright in this 
difficult and complex area. Many thanks to 
Jenny Laraman for her editing expertise.
Glenn Rees
Chief Executive Officer
Alzheimer’s Australia
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FOREWORD BY A FAMILY CARER
The Alzheimer’s Australia National Consumer 
Advisory Committee commissioned work on 
dementia and end-of-life issues for two 
reasons.
First, because of a general concern that people 
with dementia and their family carers do not 
understand their rights and options in relation 
to financial and medical decisions at the end of 
life. These difficulties are compounded by a 
poor level of understanding in the community 
about dementia and also by the lack of 
appropriate counselling and advice about the 
currently available legal options.
Our belief is that this results in people living 
with dementia making less use than they 
should of currently available legal options, 
thereby depriving themselves of the peace of 
mind that can come from knowing their rights 
and that these will be respected.
Some will take the view that increased 
resources, including better information and 
counselling, could make the current system 
work much better for people with dementia 
and their family carers. Others will take the 
view that more active approaches to 
termination of life, including euthanasia or 
assisted suicide, should be available.
The second reason for commissioning work on 
end-of-life issues is to assist Australians, and in 
particular those living with dementia, to better 
understand the additional end-of-life options 
which are under discussion. That is the 
purpose of this publication. We have not 
sought to argue for a particular position but 
rather we seek to assist people living with 
dementia, and their carers/families, to be 
better positioned to take part in what we 
anticipate will be a vigorous national debate 
over the coming years.
Many of the issues discussed are of general 
relevance to all Australians but there are 
particular issues that need consideration in 
respect of those with dementia. These are 
discussed in the last section of this publication.
I should like again, on behalf of the Ethics 
Subcommittee of the Alzheimer’s Australia 
National Consumer Advisory Committee, to 
thank Professor Colleen Cartwright for being 
so willing to undertake the writing of this 
publication. We are even more grateful for her 
openness and willingness to take on board the 
many different comments from different 
quarters that she has received from the 
Subcommittee.
We hope that this publication will assist 
Australians generally, and people living with 
dementia in particular, to discuss issues that, if 
we are honest, we all seek to avoid to our own 
disadvantage.
Elizabeth Fenwick
Chairperson
Ethics Subcommittee
National Consumer Advisory Committee
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SECTION 1:
OVERVIEW
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Part 1 of this publication explained what 
dementia is and what receiving such a 
diagnosis means. It then discussed options for 
Advance Planning – both for financial matters 
and for personal care and medical treatment 
that might be wanted or not wanted at the end 
stage of life. The issue of capacity to make 
choices relating to such planning was then 
explored, including who has the legal authority 
to make such decisions if the person with 
dementia cannot do so.
Part 1 then outlined the options that the law 
currently allows, including such things as 
refusal of food or medical treatment, adequate 
pain control, resuscitation, terminal sedation 
and palliative care. Issues for carers, funeral 
arrangements and bereavement care were also 
considered in Part 1 and a list of resources and 
helpful contacts was provided (Part 1 is 
available at www.alzheimers.org.au).
Part 2 of the publication is a discussion about 
additional end-of-life options which may 
become legally available at some time in the 
future, i.e., assisted death (usually called 
euthanasia or assisted suicide). Alzheimer’s 
Australia is not advocating that such options 
become available and takes a neutral position 
about them. However, there is a need for an 
informed debate on the issues, given that 
well-conducted research indicates that a 
significant proportion of the community 
supports making such options available.1 2 3 4
Some people believe that they should have the 
right to make decisions about their own bodies 
and about the way they die; in other cases 
people see the current legal and medical 
options as inadequate. While Australia was the 
first place in the world to pass legislation 
allowing both euthanasia and 
physician-assisted suicide (i.e. the Northern 
Territory Rights of the Terminally Ill Act (1995)), 
that legislation was overturned by the 
Commonwealth’s Euthanasia Laws Act (1997) 
and at present these options are illegal 
throughout Australia. However, given that 
assisted dying Bills are regularly presented to 
state/territory parliaments in Australia (e.g. the 
recent: Western Australian Voluntary 
Euthanasia Bill 2010, introduced to the 
Parliament by the Hon Robin Chapple on 20 
May 2010; the South Australian Voluntary 
Euthanasia Bill 2010, introduced to the 
Parliament by the Hon Bob Such MP on 24 
June 2010; and the Restoring Territory Rights 
(Euthanasia Laws Bill) introduced into Federal 
Parliament on 29 September 2010 by the Hon 
Bob Brown, leader of the Greens Party), it is 
possible that, at some time in the future, 
legislation will be passed that allows such 
options. It is therefore important for the 
arguments for and against assisted dying to be 
understood and for open debate to be 
encouraged. We hope that the information 
provided in this document will contribute to 
that debate.
Section 2 of Part 2 asks: What is 
doctor-assisted dying*? and identifies what is 
and what is not euthanasia. In Section 3, 
arguments for and against doctor-assisted 
dying are provided and in Section 4 some 
issues which relate specifically to assisted 
dying for people with dementia are considered.
*(Note: while it is possible in some countries, 
such as Switzerland, for people to be assisted 
to die by someone other than a medical 
practitioner, in most countries – including 
Australia – legislation which has been enacted 
or proposed limits the carrying out of such 
actions to medical practitioners and therefore 
the term “doctor-assisted dying” will be used 
in this publication).
SECTION 2:
WHAT IS DOCTOR-ASSISTED DYING?
The terminology most often used when 
referring to doctor-assisted dying is euthanasia 
and physician-assisted suicide.
Three definitions of euthanasia
The European Association for Palliative Care 
defines euthanasia as “A doctor intentionally 
killing a person by the administration of drugs, 
at that person’s voluntary and competent 
request”. 5
In Australia, the Senate Standing Committee 
on Legal and Constitutional Affairs, in its report 
on the Rights of the Terminally Ill (Euthanasia 
Laws Repeal) Bill 2008 defined active 
euthanasia as “where medical intervention 
takes place, at a patient’s request, in order to 
end the patient’s life”. 6
The definition used in studies by Steinberg et 
al, 1996a & b and Cartwright et al, 1998, 2002 
is:
Euthanasia is a deliberate act intended to 
cause the death of the patient, at that patient’s 
request, for what he or she sees as being in 
his/her best interests.
That is, it is active (involving a deliberate act); it 
is voluntary (at the request of a competent 
patient); it is euthanasia in its original meaning 
of a good or peaceful death; and the primary 
intention of the act is to cause the death of the 
patient.
Definition of physician-assisted suicide: A 
final definition is the distinction between active 
voluntary euthanasia (AVE) and 
physician-assisted suicide (PAS). 
Physician-assisted suicide relates to:
the doctor giving a person advice about how to 
commit suicide, giving the person a 
prescription for medication to use for suicide, 
preparing a mixture for the person to take to 
commit suicide and/or setting up equipment 
for the person to use to commit suicide. It 
does not include performing the action, such 
as giving the person an injection of the drugs. 7 
8 9 10
What euthanasia is not: There is a great deal 
of fear in the general community about the end 
stage of life. Many problems stem from 
confusion over what is, or is not, euthanasia. 
Some commonly held beliefs are that 
euthanasia includes:
(a) giving increasing amounts of needed pain 
relief which may also have the effect of 
shortening the person’s life; or
(b) respecting a patient’s right to refuse further 
treatment where such refusal will result in the 
patient’s death; or
(c) withholding or withdrawing life support 
systems that have ceased to be effective or 
that will provide no real benefit to the patient; 
or
(d) terminal sedation.
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None of these is euthanasia, as explained 
below.
(a) Giving pain relief which may also 
shorten life is often referred to as “the 
doctrine of double effect” – the primary 
intention is to relieve pain; a secondary, 
unintentional effect may be the hastening of 
the person’s death by a few hours or days. In 
Australia, the UK and many other countries 
“double effect” is accepted by most religious 
and medical groups, including those who 
strongly oppose euthanasia, such as the 
Catholic Church. Conversely, not giving 
adequate pain treatment when it is needed 
may actually shorten life: the patient may 
suffer complications such as life-threatening 
cramps or severe respiratory problems if 
severe pain is left untreated. Leaving someone 
in pain is abuse and there have been several 
successful legal cases in the US where 
doctors and/or hospitals have been sued for 
inadequate treatment of pain. 11 12 13 14 In 
addition, some Australian legislation (e.g. 
South Australia’s Consent to Medical Treatment 
and Palliative Care Act 1995) offers specific 
protection to doctors who provide medical 
treatment with the intention of relieving a 
patient’s pain or other symptoms and the 
doctor will not be liable for civil or criminal 
action even if the treatment hastens the 
patient’s death.
(b) Respecting a patient’s right to refuse 
treatment was fully explained in Part 1; in brief 
it is a legal and moral right of every competent 
person, through a current refusal, and is also 
the right of a person who is no longer 
competent but who expressed such a refusal 
in an Advance Directive or requested a 
substitute decision-maker to refuse on their 
behalf, even if such refusal will result in the 
patient’s death.
(c) Withholding/withdrawing futile 
life-support systems, also explained in Part 1, 
used to be called “passive euthanasia” but 
that term is not only inaccurate – and therefore 
unhelpful - but it can lead to the inappropriate 
continued use of invasive technology that often 
is not prolonging life, but is merely prolonging 
the dying process. Removal of futile treatment 
is good medical practice. Futility is generally 
considered to be when burden outweighs 
benefits – but “burden” and “benefit” should 
usually be from the patient’s viewpoint.
(d) Terminal Sedation, as noted in Part 1, is a 
recent, controversial addition to the discussion 
about what is legally allowed in relation to 
end-of-life care. It refers to the use of sedative 
drugs to induce unconsciousness in terminally 
ill patients in order to relieve suffering, 
including anxiety, when other attempts at relief 
have failed. It includes withholding or 
withdrawing artificial nutrition and hydration 
and is used extensively in the UK. 15 Some 
doctors have described terminal sedation as 
“slow euthanasia” and claim that it is ethically 
inferior to euthanasia because it takes patients 
longer to die, with the potential for further 
suffering. Others disagree and argue that the 
major concern is patient care and comfort. 
Some palliative care clinicians prefer the term 
“palliative sedation”, since calling it “terminal 
sedation” may suggest that it is euthanasia, 
with the result that treatment for intractable 
terminal suffering may be under-prescribed.
Cellarius16 notes that:
Although terminal sedation has received 
widespread legal and ethical justification, the 
practice remains ethically contentious ... [I]t is 
clear that providing terminal sedation in 
combination with the withholding or 
withdrawing of life-prolonging treatments such 
as fluid and nutrition can foreseeably hasten 
death significantly—what is here called early 
terminal sedation (ETS). There are ethical 
justifications for the use of sedation in 
palliative care and thus it would seem that ETS 
is an ethically and legally acceptable practice.
In Summary: giving pain relief which may also 
shorten life, accepting a person’s right to 
refuse medical treatment or to have treatment 
withheld/withdrawn (whether that 
refusal/request is given in the immediate 
present by a person who still has capacity, or 
through an advance directive or substitute 
decision-maker by a person who has lost 
capacity, such as someone with advanced 
dementia) is not euthanasia; they are actions 
which allow the person to die naturally from 
their underlying disease (for the purposes of 
this publication, that disease is dementia). 
From this point on, AVE will be used to apply 
to both euthanasia and physicianassisted 
suicide.
SECTION 3:
ARGUMENTS FOR AND AGAINST AVE
Few issues have the power to incite such 
strong emotions and heated debate as that of 
AVE, and whether or not the law should allow 
it as an option for terminally ill patients. In 
most cases, both proponents and opponents 
of AVE are people of good will grappling with 
how to achieve what they see as the best 
options at the end of life.
Examples of the most common arguments for 
and against AVE and whether or not it should 
be legalised – and responses to those 
arguments - are presented in Sections 3.1 – 
3.3 but it is acknowledged that there are many 
more ethical, philosophical, religious and 
practical arguments on this topic than can be 
included here. The arguments are complex and 
it is unlikely that universal consensus on this 
issue will be ever be reached.
3.1 Arguments in Favour of AVE and 
Responses to those Arguments:
The most common arguments in favour of AVE 
(and legislation allowing AVE) relate to: 
compassion for suffering at the end of life; 
death with dignity; autonomy, 
self-determination and control; the need for 
openness, honesty and accountability; social 
justice issues; majority rule in a democracy; 
and that if AVE is legalised, patients won’t 
need to end their lives prematurely.
• Compassion and relief from suffering: 
those who support euthanasia argue that the 
current law lacks compassion and mercy, 
forcing patients to continue to suffer and 
denying doctors the option of ending the 
patient’s agony, which can sometimes only be 
achieved by rendering the patient unconscious 
or assisting them to die. Patients may wish to 
not only relieve their own suffering but also the 
suffering of the people they love. Proponents 
of the compassion argument also claim that 
because AVE is illegal, some patients resort to 
suicide, often by more painful methods, such 
as gunshots or hanging.
Responses to these arguments include that 
palliative care can provide adequate comfort 
for pain and suffering and that distress is 
labelled ‘unrelievable’ when the real problem is 
that
health care providers are inexperienced in 
palliative care.
• Death with dignity: the argument here is 
that patients have a right to preserve their 
dignity and that death (especially in a hospital 
setting) can be very undignified, especially if 
the person is incontinent and/or connected to 
machines. Many people fear that the last 
memories their loved ones have of them will 
not be how they wish to be remembered.
The main response to this argument is that 
preserving a person’s dignity depends more on 
the attitudes of those around them – families 
and staff – and on the courtesy and respect 
afforded to them than it does on the treatment 
they are receiving.
• Patient autonomy, self-determination 
and control: Arguments here include: respect 
for individual autonomy and self-determination 
are fundamental principles in Western medical 
ethics and decision-making, often expressed 
as a desire for control over the timing and 
manner of death. A competent, terminally ill 
patient, who has judged that their suffering 
makes continued life an unwelcome burden, 
should be able to request a medical 
practitioner to bring about their death. 
Prohibiting AVE is a restriction on liberty and 
autonomy. Given that the right to refuse 
treatment, even if that refusal will result in 
death, is both a legal and a moral right (as 
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explained in Part 1), there should be the same 
moral right to AVE. For people who are 
physically unable to bring about their own 
death, this should include the right to be 
assisted to die.
Responses to these arguments include that, 
because AVE requires the assistance of a 
second person, it is not just one person’s 
autonomy or self-determination that is at issue 
and a right to die does not equate to a right to 
be killed. Autonomy is never absolute; the 
legitimate competing rights of other people or 
of society must also be taken into account - 
the potential bad consequences may outweigh 
the good. There is a risk that physicians who 
do not know how to adequately relieve a 
patient’s suffering may agree to end that 
patient’s life. Patient autonomy is an illusion 
when the choice becomes continued agony or 
a hastened death.
• The need for openness, honesty and 
accountability: Both anecdotal and research 
evidence demonstrates that the practice of 
AVE already occurs; providing that they are 
sure that their responses are confidential, 
doctors and nurses acknowledge that they 
assist patients to die, including where it is not 
legal to do so. However, because it is currently 
illegal, there cannot be open discussion about 
it and grieving families/loved ones have to 
pretend that something different occurred from 
what they know to be the case. If AVE were 
legalised it could be discussed openly, allowing 
relatives and friends to also grieve openly. 
Because of the illegality, and/or the social 
stigma attached to AVE, there can be traumatic 
psychological consequences for family 
members and others involved, including 
feelings of guilt and fear of detection. To 
protect loved ones from this, some patients 
who desperately want to die feel forced to go 
on living.
Decriminalisation would also allow the 
development of better practices, including 
doctors working with pharmacists to develop a 
documented regimen of drug use producing 
least sideeffects. When AVE is practiced in 
secret, problems can, and do, occur, e.g. 
patients do not die after being given all 
available medication, leading in some cases to 
a family member having to take actions to end 
the person’s life. The resulting trauma is 
obvious and long-lasting.
Response: Even where assisted death is legal, 
technical difficulties and other complications 
are still sometimes experienced, resulting in 
diminished, not enhanced, quality of end-of-life 
care.
• Social justice: Many people who are 
well-educated and in the higher 
socio-economic groups, who know who to ask 
and how to ask, have access to AVE while the 
rest of the community does not. Also, patients 
whose diseases make them dependent on 
machines or other technology can control their 
time of dying by requesting that treatment be 
withheld or withdrawn while patients who are 
not technology-dependent do not have the 
same right. This is discriminatory and 
proponents argue that, given that there is no 
moral difference between withholding or 
withdrawing life support and providing AVE, 
those who are not technologydependent 
should be provided with assistance to die if 
they request it.
Other arguments in this group include that: 
there is no intrinsic moral difference between 
killing and letting die because both intention 
and outcome are the same; it is morally worse 
to prolong someone’s suffering rather than kill 
them; and it is unjust to prolong someone’s life 
by a range of interventions but then refuse 
them assistance to die at the end.
Response: There is indeed a moral distinction 
between taking life and withdrawing 
inappropriate treatment to allow death to 
occur, and between making a person die and 
letting a person die. Intention to relieve pain, 
even if death is thereby hastened, is morally 
different to intention to end the patient’s life.
• We live in a democracy and the majority 
want it: The majority of the general 
community support the legalisation or the 
practice of assisting terminally ill patients to 
die if that is what they want. This is evidenced 
by both opinion polls and academic research. If 
such a law has majority support, the minority 
may choose not to have anything to do with it 
but should not deny the option to those who 
want it.
Response: Many surveys are flawed because 
questions are ambiguous or “leading”, and the 
general public hold misperceptions about 
medical practices; some people say they 
support euthanasia when they actually support 
giving adequate pain relief, something which is 
already legally available.
• If AVE is legalised, patients won’t need 
to end their lives prematurely: An additional 
argument in favour of legalising AVE is that if 
patients know AVE is available, they may delay 
taking action or not take up the option at all. 
Some terminally ill people kill themselves 
before they really want to, for fear of losing the 
ability to do so through hospitalisation or 
disability. Legalising AVE would give patients 
peace of mind and reassurance that they could 
control their own dying, should they need to.
Response: If patients and their carers receive 
adequate support and counselling, including 
high-quality palliative care, and are encouraged 
to focus on life rather than death, they may not 
want to end their lives at all.
3.2 Arguments against AVE Legislation (not 
against AVE) and Responses to those 
Arguments:
Another group of arguments is proposed by 
those who are not opposed to AVE but who do 
not believe that it should be legalised. These 
arguments include: fear of abuse/coercion; 
concern about “the slippery slope”; and the 
claim that palliative care can adequately control 
suffering if properly resourced.
• Fear of abuse/coercion: If AVE were 
legally available, some people might be directly 
or indirectly pressured into requesting it by 
families who are no longer able or willing to 
carry the burden of care, or by health 
professionals who feel helpless to provide 
further medical treatment, or by a health 
system that wants to save money. Others 
would request it in order to remove the burden 
of their care from their families. Vulnerable 
patients, such as these who are old, poor or 
mentally ill could also be coerced into 
requesting it. The right to AVE could become 
the duty to accept AVE or having to justify not 
asking for AVE.
Response: Patients can already be coerced 
into refusing treatment or requesting that 
treatment be withdrawn, both actions intended 
to bring about their death, yet that is legally 
available. Many people feel forced to go on 
living when they would rather die.
• The slippery slope argument: The majority 
of slippery slope arguments contain all or 
some of the following claims: that abuse of 
legalised AVE cannot be prevented; once it is 
allowed for competent, terminally ill people 
numbers requesting it will increase 
dramatically and it will then be extended to 
terminally ill people who are no longer 
competent, then perhaps to non-terminally ill 
people who may never have been competent 
and finally to those vulnerable patients who 
may be competent but whose lives are judged 
by others to be “not worth living” (e.g. those 
who have a severe physical disability or 
advanced dementia or who are simply “too 
old”). The abuses of Nazi Germany are seen as 
evidence of such a “slippery slope”; in the 
Australian context it was argued that the 
Northern Territory’s Rights of the Terminally Ill 
Act risked indigenous people’s lives being 
ended prematurely, with the history of 
white-on-black racial discrimination being seen 
as cause for concern.
Responses: If the slippery slope is a probable 
consequence of legalising AVE, why has it not 
been a result of allowing treatment refusal or 
withdrawal? Why should allowing AVE weaken 
society’s general abhorrence of killing, if killing 
in war and/or self-defence has not already 
done so? The reasons that justify AVE - mercy 
and respect for autonomy - cannot logically 
also justify killings that are neither merciful nor 
show respect for autonomy. Carefully tested 
safeguards can include: AVE only being 
available to competent adults who give fully 
informed consent; and psychiatrists ensuring 
that those with serious mental illness cannot 
access AVE in a crisis. What the Nazis did had 
nothing to do with euthanasia, (i.e. a good or 
peaceful death), it was murder. Use of qualified 
interpreters and procedural safeguards could 
deal with communication issues in indigenous 
populations; such patients would be more 
likely to experience barriers to obtaining AVE 
than risk having it when they do not want it. 
Evidence from the Netherlands indicates that 
the percentage of very old people who receive 
AVE is very small compared to other age 
groups and people who cannot request AVE 
are more likely to receive terminal sedation 
than AVE.
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• Palliative care can control pain and other 
suffering and should be better resourced:
Requests for AVE are calls for help because 
end-of-life care needs are not being met. With 
an ageing population and limited health-care 
resources, governments would see AVE as a 
less-costly alternative to good palliative care*, 
requiring fewer resources. Until all patients 
have equal access to palliative care, AVE 
should not be an option.
Responses: Patients still ask for AVE, even 
when they are pain-free and exemplary 
palliative care is provided. Palliative care may 
control most pain but cannot always control 
non-physical suffering, nor some physical 
symptoms such as nausea, breathlessness, 
inability to swallow and extreme weakness. 
What counts as intolerable suffering is a 
subjective matter. Dying, including when and 
how to die, is a personal and social problem, 
not just a medical issue. Since only a small 
percentage of terminally ill people request 
assistance to die, even where it is a legal 
option, the needs of the majority will still have 
to be met, so palliative care must be 
well-resourced, but this will not remove all 
requests for AVE.
(*Note: The enactment of The Rights of the 
Terminally Ill Act in the NT actually saw an 
increase in government funding for palliative 
care in that state, perhaps to ensure that the 
government did not see AVE as a less-costly 
alternative to palliative care).
3.3 Arguments Against AVE and Responses 
to those Arguments:
The final group of arguments is made by those 
who strongly oppose AVE. Such arguments 
relate to: religious convictions/sanctity of life; 
knowing when requests are truly informed and 
autonomous; the possibility that AVE could 
destroy trust between patients and doctors; 
and the medicalisation of the end of life that 
AVE would bring about.
• Religious convictions and a belief in the 
sanctity of life: Only God has the right to 
control life and death. The principle of sanctity 
of life means that it is never acceptable to 
intentionally kill an innocent human being. To 
terminate a patient’s life, even at his or her 
request, would violate divine law in a crime 
against life itself.
Responses: Sanctity of life is not an absolute 
nor is AVE explicitly forbidden in the Bible. 
What appears in some texts as “thou shall not 
kill” is actually “thou shall do no murder”. In a 
democratic society, it is unacceptable for some 
people to impose their religious beliefs on 
others or to compel those who have different 
values to die painful or protracted deaths. 
Patients or doctors who have religious 
objections do not have to take any part in AVE. 
Medicine has conflated sanctity of life with the 
increasing scope of technological advances to 
prolong life, thus making acceptance of death 
morally suspect.
• The problem of knowing when requests 
are truly informed and autonomous: There 
are so many factors that may propel a person 
to request AVE (some of them possibly not 
even recognised by the patient themselves) 
that it is doubtful that such requests could ever 
be said to be truly voluntary. If people feel 
useless and a burden, or are otherwise 
vulnerable, the choice for AVE may not really 
be a free choice but may be coerced by socially 
limiting options.
Responses: A competent person whose 
condition is unlikely to improve (and perhaps 
may become worse) and who has decided that 
their present state is intolerable is making a 
legitimate request, even though they made 
their decision while suffering. If the person is 
no longer competent but they made their 
decision in a legal advance directive while they 
were free of distress and had a clear mind, 
their wishes should be accepted as 
autonomous and voluntary.
• Euthanasia would destroy trust between 
doctors and patients, and between doctors 
and the community: AVE is fundamentally 
inconsistent with the physician’s role of healer. 
Legalisation will undermine the public’s trust in 
the medical profession and dramatically change 
the nature of the doctor-patient relationship.
Responses: Legal cases, even those involving 
refusal of life-sustaining treatment, have 
rejected the notion that the ethical integrity of 
the medical profession might, at times, 
over-ride patient self-determination. Trust 
between patients and their doctors could be 
increased, not eroded, by knowing that the 
doctor will assist the patient to die under some 
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circumstances. AVE is entirely consistent with 
one of the highest ideals of medicine, i.e., to 
do everything possible to promote patients’ 
well-being while completely respecting 
patients’ autonomy.
• AVE would increase the medicalisation 
of the end of life: a medical intervention 
would bring about the person’s death.
Response: Having to continue living with 
medical technological support, against one’s 
will, increases the medicalisation of the end of 
life more than would legalising assistance in 
dying.
3.4 Additional Issue Related to the 
Challenges of a Federal Legislative 
System*:
Australia is a federation of states and 
territories, which constitutionally all make their 
own health law, resulting in different legislative 
provisions, documentation and terminology. 
This is already providing a significant challenge 
for a National Working Party 17 in trying to 
achieve national consistency in relation to 
Advance Care Planning and use of Advance 
Directives. It is reasonable to assume that this 
problem would increase significantly if any 
state or territory passes legislation allowing 
AVE.
“AVE tourism” is already a reality in Europe, 
with people travelling to Switzerland from 
other countries, including Australia, to access 
the assisted-suicide provisions which exist in 
that country. In Australia, when the NT Rights 
of the Terminally Ill Act was in place, one of the 
first people to attempt to use the legislation 
was a man from Broken Hill in NSW, who 
travelled to Darwin expecting to be assisted to 
end his life by Dr Philip Nitschke. Although this 
did not happen because all certification 
required under the legislation could not be 
obtained, it is reasonable to assume that 
terminally ill people, or those with dementia, 
would travel to any state or territory in which 
AVE was legally available.
Response: Any legislation would require 
carefully thought-out regulations to deal with 
“AVE shopping”. These could include residency 
requirements and/or established relationships 
with medical practitioners in the state/territory.
* Note: A National approach would be ideal but 
is probably unlikely.
In summary, as previously identified, there are 
many complex arguments on all sides of this 
debate and it is unlikely that consensus on this 
issue will be ever be reached.
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SECTION 4:
SPECIFIC AVE ISSUES FOR PEOPLE WITH DEMENTIA
All of the issues and arguments discussed 
above take on an additional level of complexity 
when they are applied to people with 
dementia. Some people with dementia live for 
many years with good – or at least acceptable 
– quality of life, even when they have lost the 
capacity to make many or most of their own 
decisions (see Part 1 of this publication for a 
discussion of Capacity). Some issues are 
presented below, followed, where appropriate, 
by responses to the statements. However, 
some issues will require much more 
discussion, debate and community-wide 
research to ensure that all the salient points 
have been considered.
4.1 Major Issues
• Distress at being diagnosed with 
dementia could trigger a request for AVE:
The trauma of a diagnosis of dementia, 
especially when that is combined with limited 
understanding of what that will mean and fear 
for their quality of life, or concern for the 
burden that loved ones will bear, may make 
AVE seem like the best option for some people 
with dementia. The stigma attached to 
dementia may also prompt such a request.
Response*: Most legislation proposed in 
Australia and overseas requires a “cooling off” 
period after the first request and also a 
discussion with a palliative care specialist to 
ensure that the person and their family/carer 
understand the help that is available.
*Note: while the responses to this issue, 
outlined above, may help to reduce the risk 
associated with distress associated with a 
diagnosis of dementia, it is acknowledged that 
this risk would nevertheless remain and that it 
is a serious issue which would require 
vigilance on the part of the family/carer and 
service providers in order to protect the person 
with dementia.
• Higher levels of support may be required 
for people with dementia: If legislation is 
passed allowing AVE, people with dementia 
would require an even higher level of 
counselling and support than is the case for 
the general population; this would need to be 
provided early in the disease process by 
counsellors skilled in working with people with 
impaired capacity and these resources are 
simply not in place.
Response: Continued lobbying of 
governments at all levels must be undertaken 
by both specialist medical and consumer 
groups to try to achieve adequate resources to 
provide the best counselling and support 
possible. However, in a country such as 
Australia with both geographical and 
multicultural challenges, “adequate resources” 
will be difficult to achieve. Nevertheless, if 
such legislation is passed, care will be needed 
to ensure that people with dementia are not 
denied access to it on the basis that adequate 
counselling is not in place, as this would 
constitute double discrimination.
• Possible effect of recent media coverage 
of increasing numbers of people with 
dementia: The stigma that attaches to 
dementia in our current society is too great to 
risk AVE for people with dementia. At its 
extreme, this attitude is reflected in a 
statement reported by the UK Daily Telegraph 
on 18 Sep 2008, where Baroness Warnock, a 
UK Government advisor on ethics during the 
1980s, said that people suffering dementia 
may have “a duty to die” because they are a 
burden on their families and the National 
Health Service 18.
Response: One of the biggest challenges for 
people working in this sector is to alert the 
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community and policy-makers to the 
undoubted large and rapid increase ahead in 
the number of people with dementia but at the 
same time to not cause so much alarm and 
fear that it results in a backlash against people 
with dementia. It is also important that media 
coverage does not make everyone in the 
community who is becoming older think that it 
is inevitable that they will develop dementia. 
While numbers of people with dementia will 
certainly increase, because of the increasing 
longevity of the population, the percentage of 
people in each age group who have dementia 
is not increasing.
Approximately 12% of people in their early 80s 
have dementia and this increases to 
approximately 25% for those aged 85 and 
above – which means that 88% of 
80-84-year-olds and 75% of those aged 85 and 
above do not have dementia! Communicating 
a balanced message will demand great skill.
• Should a previously expressed wish for 
AVE by a person with dementia be 
respected? A person who may previously have 
expressed a wish for AVE when their condition 
reached a particular level would no longer be 
able to competently request that when the 
time came, even if it was legally available by 
then. If previously expressed wishes are to be 
actioned, there would need to be very careful 
regulations about how such wishes are 
recorded. Options for people with dementia 
could include writing their wishes in an 
Advance Directive when they were in the early 
stages of the disease and still had capacity 
and/or they could ask their legally-appointed 
substitute decision-maker to organise AVE for 
them at a particular point in their disease 
process.
Opponents of AVE claim that advance requests 
for AVE are not uncommon in places such as 
the Netherlands and Belgium. However, 
Hertogh19 in an “evaluation of the practice of 
euthanasia” in the Netherlands, found an 
“absence of euthanasia cases concerning 
patients with dementia and a written advance 
euthanasia directive”. He suggests two 
principal reasons for this absence: one is that it 
is not possible to be certain that the patient is 
truly experiencing the suffering they feared; 
the second is that advanced dementia 
prevents the opportunity for shared 
decision-making between the patient and 
doctor that euthanasia should entail. This 
finding is supported by a broadcast by Radio 
Netherlands Worldwide on 24 November 2010 
(downloaded 12/1/11) which indicated that 
most doctors in the Netherlands would not 
proceed with a request for AVE in an Advance 
Directive, particularly if it was completed some 
years before, because they require the person 
to confirm, at the time that AVE is to be 
administered, that this is still what they want.
It is also difficult to see how asking for AVE in 
an Advance Directive or through a substitute 
decision-maker is different to asking in an 
Advance Directive or through a substitute 
decisionmaker for life-sustaining treatments to 
be withheld or withdrawn at a given stage of 
illness – options that are currently legally 
available – given that both actions (AVE and 
withdrawing/withholding treatment) will result 
in death.
There could be a degree of difference if the 
person completed the Advance Directive or 
gave their instructions many years previously, 
based on what they thought their life might be 
like if they had advanced dementia, if once 
they actually reached that stage they appeared 
to be comfortable and not in distress. This 
could raise doubts about the validity of 
respecting the Directive or the instructions of a 
substitute decision-maker. In such cases a 
treating medical practitioner who might be 
prepared to provide AVE should seek advice 
from their hospital ethics committee or from 
the Public Guardian (or equivalent) in their 
particular state/territory before proceeding.
• Should others be able to request AVE for 
people with advanced dementia?
Response: We understand too little about how 
a person with dementia feels to be confident 
about taking such decisions on their behalf. If 
AVE becomes legally available and a person 
with dementia has not specifically requested 
that they are to receive it, they should not 
receive it. There would be no evidence that this 
is what the person would choose for 
themselves, were they competent to speak. 
Many people working in this field strongly 
advocate that the term “euthanasia” should 
only ever be used in relation to a specific 
request from a competent person. If the 
person with dementia who has not requested 
AVE was obviously in pain or otherwise 
distressed, medical procedures should be 
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utilised to provide the best comfort care and 
symptom relief for them, even if this 
subsequently hastened their death, but such 
actions should not be called euthanasia.
It would also be a very big burden for a 
substitute decision-maker to carry (whether 
that person was appointed by the patient 
themselves or was the legally authorised “next 
in line” to make substitute decisions) if they 
had to make such a decision.
• Should a request for AVE made while 
this is illegal be honoured if AVE is legal at a 
later time? A person who receives a diagnosis 
of dementia now, while AVE is illegal in this 
country, may request in their Advance Directive 
that they be provided with AVE when/if they 
reach a specific set of conditions in their 
illnesses trajectory “provided legislation is then 
in place which would allow for such an action”.
Response: It is difficult to predict what a court 
would decide in such a case, given that what 
the person requested was illegal when the 
request was made but was posited against the 
action becoming legal when it was required to 
be provided.
4.2 Other Issues
Three other issues of particular relevance to 
end-of-life care of people with dementia, which 
are frequently misrepresented as AVE, are: 
adequate pain management; withholding 
artificial nutrition and hydration; and treatment 
of pneumonia or other infections with 
antibiotics. These issues were discussed at 
length in Part 1 in relation to people with 
dementia. A summary of the issues is 
repeated here because these actions are 
frequently misconstrued as AVE when they are 
absolutely not – they are legally sanctioned 
actions which are an essential part of good 
end-of-life care.
Adequate pain management: Every person 
(competent or not) has the right to adequate 
control of pain and other symptoms; to leave 
someone in pain or distress is abuse, yet 
research shows that people with dementia 
often die with inadequate pain control.20 The 
Nuffield Council on Bioethics 21 notes that:
[T]here is evidence that people with dementia 
experience poor care at the end of their lives, 
with badly controlled pain ... (and that) ... 
recent research in the UK has suggested that 
amongst older people who die in hospital, 
those who have dementia are less likely to 
receive palliative medication ... than people 
who do not have dementia.
With good palliative care, almost all dying 
patients can be kept comfortable but still 
“awake” enough to communicate with family 
and friends. Proper assessment of pain in 
people with dementia is a skill which many 
health care providers lack; if someone no 
longer has capacity they may lack the ability to 
tell someone that they are in pain. However, 
good assessment tools, such as the Abbey 
Pain Scale 22, are available and every health 
care professional who works with people with 
dementia or terminally ill people should be 
trained to use these tools. Giving adequate 
pain relief, even if it subsequently hastens the 
person’s death by a few hours or days, is not 
AVE, it is good medical care. In fact, leaving 
someone in severe pain can hasten their death 
as they can suffer cramping or respiratory 
distress because of the pain.
Sometimes a patient’s pain relief is 
compromised because families fear the use of 
morphine and object to its use, thinking that 
giving it equates to AVE. This is not the case 
but the treating health care professionals may 
need to give the family sufficient information 
for them to understand that morphine – or any 
other drugs – will only be given in the doses 
needed to control the person’s pain or other 
symptoms. While death may be hastened, the 
intention is to relieve the patient’s pain and 
other symptoms and their death will be a 
result of their illness, not of the medication. 
AVE should never be a substitute for adequate 
pain relief.
(Note: While seldom confused with AVE, an 
important issue related to adequate 
management of pain and other symptoms is 
access to good palliative care. The quality and 
availability of palliative care varies 
tremendously, especially for people in rural and 
regional communities. This problem is 
exacerbated for people with dementia because 
many palliative care practitioners have little or 
no training in providing palliative care to people 
with dementia. See Section 3 in Part 1 of this 
publication for a thorough discussion of the 
issue of palliative care for people with 
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dementia).
Withholding artificial nutrition and 
hydration (food or fluids): For a person with 
dementia, loss of the swallowing reflex is a 
normal part of advanced dementia, and a sign 
that death is approaching. To continue artificial 
nutrition and hydration** when the person has 
reached this stage of their illness can actually 
increase their suffering 23 and even deprive 
them of a peaceful death. 24 25 (See Part 1 of 
this publication for more information about 
this).
(**Artificial nutrition and hydration: food or 
fluid provided through a tube down the 
person’s nose or a tube inserted directly into 
the stomach).
It can be very challenging for carers and other 
family members to understand and accept that 
the person with dementia no longer wants or 
needs food or fluids. Carers or family members 
may feel helpless and think that providing food 
for the person they love is at least “doing 
something”. Unfortunately, what they may be 
doing is causing the person distress and 
discomfort – or even actual suffering. 
Withholding artificial nutrition and hydration 
from a person with advanced dementia is not 
AVE, it is good medical care.
Refusal of antibiotics: “Pneumonia is 
common among patients with advanced 
dementia, especially towards the end of life”. 26 
Unless they have been specifically refused, 
antibiotics are often used to treat pneumonia, 
even in terminally ill people with dementia, 
based on the assumption that this will both 
prolong life and improve comfort. However, in a 
6-year study conducted by Givens et al (2010) 
of over 320 nursing home residents with 
advanced dementia, the researchers found that 
while such treatment was associated with 
prolonged survival it did not improve the 
comfort levels of the patients with advanced 
dementia. This raises the question, “Is it 
ethical to prolong the life of a person in such a 
condition?” Again, not giving antibiotics to 
such patients is not AVE – while the research 
did show prolonged survival, in reality it is not 
prolonging their life, it is merely prolonging 
their dying.
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SUMMARY
The issues outlined above, and in Part 1 of this 
publication, illustrate just how complex the 
issue of end-of-life care is for people with 
dementia. The rights and needs of many 
stakeholders have to be taken into account:
• patients have a right to the best quality of 
life possible; to have their wishes respected 
within the limits of the law; and at the end of 
life they need – and have a right to receive – 
exemplary care, especially in relation to pain 
and symptom management;
• carers have a right to be supported so the 
burden does not become too great; they have 
a need for good information about medical, 
legal, financial, social and ethical issues and, 
where possible, training to help them 
undertake the demanding work that they do;
• doctors have a need for better training to 
understand how to care for people with 
dementia and their families, as well as better 
training in pain management and palliative 
care; they also need information about the 
legal rights of the patients and of themselves;
• nurses also require better information and 
training and they also need to be 
acknowledged for the excellent work that 
many of them do to support their patients and 
their families, often beyond the call of duty.
If AVE ever becomes legally available the main 
challenge will be to support those who clearly 
want it to record their wishes and work with 
their carers to achieve the patient’s desired 
outcomes while at the same time strongly 
protecting those who do not want it. In the 
meantime, a much bigger investment is 
needed to promote awareness and 
understanding of dementia.
For a thorough understanding of all of the 
issues around end-of-life care for people 
with dementia and their families, we 
recommend that Part 1 and Part 2 of this 
publication be read as one document.
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September 2004
National Consumer Summit on Dementia 
Communique. October 2005
Mind Your Mind: A Users Guide to Dementia 
Risk Reduction 2006
Beginning the Conversation: Addressing 
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VISIT THE ALZHEIMER’S AUSTRALIA WEBSITE AT
WWW.FIGHTDEMENTIA.ORG.AU
FOR COMPREHENSIVE INFORMATION ABOUT
DEMENTIA AND CARE
INFORMATION, EDUCATION AND TRAINING
OTHER SERVICES OFFERED BY
MEMBER ORGANISATIONS
OR FOR INFORMATION AND ADVICE CONTACT THE
NATIONAL DEMENTIA HELPLINE ON
1800 100 500
(NATIONAL DEMENTIA HELPLINE IS AN AUSTRALIAN GOVERNMENT FUNDED INITIATIVE)
